A safety evaluation of budesonide MMX for the treatment of ulcerative colitis

Expert Opinion on Drug Safety
Cristina BezzioSimone Saibeni

Abstract

Budesonide belongs to low-bioavailability steroids class. A novel oral formulation of budesonide, which uses the Multi-Matrix System (MMX) for delivering drugs to the colon, is now available as a possible treatment of ulcerative colitis patients intolerant or not-responding to first-line therapy with 5-ASA. Areas covered: in this review we present information about the development and the use of budesonide MMX and we provide data about its mechanism of action as well as, pharmacodynamics and pharmacokynetics. Moreover, we present the available literature data about the efficacy and, mainly, the safety of budesonide-MMX. Expert opinion: budesonide-MMX is a new therapeutic option in mild-to-moderate UC patients. Its good safety profile in clinical trials undoubtedly represents a strength for a possible wide use in clinical practice, mainly if it will be confirmed by post-marketing data. Other indications, such as treatment of colonic Crohn's disease, could theoretically be considered, if sustained by reliable scientific data.

References

Nov 9, 2000·Alimentary Pharmacology & Therapeutics·C PapiL Capurso
May 11, 2002·The American Journal of Gastroenterology·Maria Cino, Gordon R Greenberg
Aug 17, 2002·Alimentary Pharmacology & Therapeutics·S V KaneB G Feagan
Sep 17, 2003·Journal of Gastroenterology and Hepatology·H R PearceN J Brown
Nov 24, 2004·Advanced Drug Delivery Reviews·Richard N Fedorak, Lana Bistritz
Feb 11, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Erik J SchoonUNKNOWN Matrix Study Group
Feb 16, 2005·Alimentary Pharmacology & Therapeutics·S HanauerT Persson
Aug 2, 2005·Immunology and Allergy Clinics of North America·Peter J Barnes
Jan 5, 2006·British Journal of Clinical Pharmacology·M BrunnerM Müller
Apr 25, 2006·Journal of Pharmacokinetics and Pharmacodynamics·Jeffrey G StarkGuenther Hochhaus
Jul 23, 2008·The Cochrane Database of Systematic Reviews·Cynthia H SeowA Hillary Steinhart
Aug 6, 2008·Inflammatory Bowel Diseases·Dawn B BeaulieuDavid G Binion
Dec 23, 2008·Scandinavian Journal of Gastroenterology·Inger Camilla SolbergUNKNOWN IBSEN Study Group
Jan 23, 2009·The Cochrane Database of Systematic Reviews·Eric I BenchimolA Hillary Steinhart
Oct 12, 2010·The Cochrane Database of Systematic Reviews·Mary E SherlockAnne Marie Griffiths
Mar 17, 2011·The American Journal of Gastroenterology·Alexander C FordPaul Moayyedi
Jun 3, 2014·Expert Review of Gastroenterology & Hepatology·Simone SaibeniFederica Fascì-Spurio
Mar 4, 2015·Nature Reviews. Gastroenterology & Hepatology·Ashwin N Ananthakrishnan
Jun 22, 2015·Journal of Crohn's & Colitis·Gary R LichtensteinWilliam J Sandborn
Nov 3, 2016·Expert Review of Gastroenterology & Hepatology·Cristina BezzioSimone Saibeni
Feb 6, 2017·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Livia BianconeUNKNOWN Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
May 16, 2017·Journal of Crohn's & Colitis·Katarzyna Karolewska-BochenekAleksandra Banaszkiewicz
May 18, 2017·Journal of Crohn's & Colitis·Marcus HarbordUNKNOWN European Crohn’s and Colitis Organisation [ECCO]
Jul 18, 2017·Journal of Autoimmunity·Marjorie ArgolloSilvio Danese

❮ Previous
Next ❯

Citations

Nov 9, 2019·United European Gastroenterology Journal·Giovanni MaconiSandro Ardizzone
Dec 29, 2020·Critical Reviews in Food Science and Nutrition·Amin AbbasiLeili Aghebati-Maleki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved